<?xml version="1.0" encoding="UTF-8"?>
<ref id="B195-vaccines-08-00224">
 <label>195.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Payne</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Iblan</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Rha</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Alqasrawi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Haddadin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Al Nsour</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Alsanouri</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ali</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Harcourt</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Miao</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus</article-title>
  <source>Emerg. Infect. Dis.</source>
  <year>2016</year>
  <volume>22</volume>
  <fpage>1824</fpage>
  <lpage>1826</lpage>
  <pub-id pub-id-type="doi">10.3201/eid2210.160706</pub-id>
  <pub-id pub-id-type="pmid">27332149</pub-id>
 </element-citation>
</ref>
